Fundraising Fox

Aisling Capital2015 Investments

2 investments dated 2015 · listed companies and verified rows first · show all

Protagonist Therapeuticsprotagonist-inc.comin𝕏NASDAQ: PTGXJul 2015

Protagonist is a company that emphasizes a diverse and inclusive corporate culture as central to its innovation, with stated goals of creating wins for its organization and for patients.

BiotechHealthtechMilpitas, US

Dinesh V. Patel, PhD(Executive Officer, Director)Dinesh Patel(President & Chief Executive Officer)

BoardAsish K. Xavier, Ph.D.(Director)Michael Panaccio, Ph.D.(Director)Armen Shanafelt, Ph.D.(Director)Paul F. Truex(Director)

Co-investorsCanaan PartnersJJDCLilly VenturesStarfish Ventures

Scholar Rockscholarrock.comin𝕏NASDAQ: SRRKDec 2015

Scholar Rock is a biopharmaceutical company that develops therapies targeting growth factor proteins to treat serious diseases.

BiotechCambridge, US

Nagesh Mahanthappa(Executive Officer, Director)Timothy Springer(Director)

BoardKristina Burow(Director)inAmir Nashat(Director)inKatrine Bosley(Director)Michael Gilman(Director)

Co-investorsARCH Venture PartnersEcoR1 CapitalPolaris Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.